|
US5693343A
(en)
|
1984-03-16 |
1997-12-02 |
The United States Of America As Represented By The Secretary Of The Army |
Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
|
|
US5417986A
(en)
*
|
1984-03-16 |
1995-05-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
|
US5762965A
(en)
*
|
1984-03-16 |
1998-06-09 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradble-biocompatible microspheres
|
|
US20030161889A1
(en)
*
|
1984-03-16 |
2003-08-28 |
Reid Robert H. |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
|
USRE40786E1
(en)
|
1984-03-16 |
2009-06-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
|
|
US6309669B1
(en)
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
|
US6410056B1
(en)
|
1984-03-16 |
2002-06-25 |
The United States Of America As Represented By The Secretary Of The Army |
Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
|
|
US6217911B1
(en)
|
1995-05-22 |
2001-04-17 |
The United States Of America As Represented By The Secretary Of The Army |
sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
|
|
GB2209937B
(en)
*
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
|
US5271945A
(en)
*
|
1988-07-05 |
1993-12-21 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsule for water soluble drug
|
|
US6323307B1
(en)
|
1988-08-08 |
2001-11-27 |
Cargill Dow Polymers, Llc |
Degradation control of environmentally degradable disposable materials
|
|
US5444113A
(en)
*
|
1988-08-08 |
1995-08-22 |
Ecopol, Llc |
End use applications of biodegradable polymers
|
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
|
AU5741590A
(en)
*
|
1989-05-04 |
1990-11-29 |
Southern Research Institute |
Improved encapsulation process and products therefrom
|
|
CH679207A5
(pt)
*
|
1989-07-28 |
1992-01-15 |
Debiopharm Sa |
|
|
US5439688A
(en)
*
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
|
US5225205A
(en)
*
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
|
MY107937A
(en)
*
|
1990-02-13 |
1996-06-29 |
Takeda Chemical Industries Ltd |
Prolonged release microcapsules.
|
|
US5238714A
(en)
*
|
1990-10-02 |
1993-08-24 |
Board Of Regents, The University Of Texas System |
Efficient microcapsule preparation and method of use
|
|
US5484584A
(en)
*
|
1990-10-02 |
1996-01-16 |
Board Of Regents, The University Of Texas System |
Therapeutic and diagnostic use of modified polymeric microcapsules
|
|
US5102402A
(en)
|
1991-01-04 |
1992-04-07 |
Medtronic, Inc. |
Releasable coatings on balloon catheters
|
|
US5153002A
(en)
*
|
1991-03-04 |
1992-10-06 |
University Of Montreal |
Biocompatible gradient controlled release implant
|
|
WO1992019263A1
(en)
|
1991-04-24 |
1992-11-12 |
The United States Of America, As Represented By The Secretary Of The Army |
Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
|
CH683149A5
(fr)
*
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
|
US5470582A
(en)
*
|
1992-02-07 |
1995-11-28 |
Syntex (U.S.A.) Inc. |
Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
|
|
US6013853A
(en)
*
|
1992-02-14 |
2000-01-11 |
The University Of Texas System |
Continuous release polymeric implant carrier
|
|
US5876452A
(en)
*
|
1992-02-14 |
1999-03-02 |
Board Of Regents, University Of Texas System |
Biodegradable implant
|
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
|
DE69311538D1
(de)
*
|
1992-03-12 |
1997-07-17 |
Alkermes Inc |
Acth enthaltende mikrokugeln mit gesteuerter abgabe
|
|
US5571166A
(en)
*
|
1992-03-19 |
1996-11-05 |
Medtronic, Inc. |
Method of making an intraluminal stent
|
|
US5510077A
(en)
*
|
1992-03-19 |
1996-04-23 |
Dinh; Thomas Q. |
Method of making an intraluminal stent
|
|
US5599352A
(en)
*
|
1992-03-19 |
1997-02-04 |
Medtronic, Inc. |
Method of making a drug eluting stent
|
|
US5591224A
(en)
*
|
1992-03-19 |
1997-01-07 |
Medtronic, Inc. |
Bioelastomeric stent
|
|
US5716644A
(en)
*
|
1992-06-11 |
1998-02-10 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
|
US6514533B1
(en)
|
1992-06-11 |
2003-02-04 |
Alkermas Controlled Therapeutics, Inc. |
Device for the sustained release of aggregation-stabilized, biologically active agent
|
|
US5674534A
(en)
*
|
1992-06-11 |
1997-10-07 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
|
US20030035845A1
(en)
*
|
1992-06-11 |
2003-02-20 |
Zale Stephen E. |
Composition for sustained release of non-aggregated erythropoietin
|
|
US5711968A
(en)
*
|
1994-07-25 |
1998-01-27 |
Alkermes Controlled Therapeutics, Inc. |
Composition and method for the controlled release of metal cation-stabilized interferon
|
|
FR2693905B1
(fr)
*
|
1992-07-27 |
1994-09-02 |
Rhone Merieux |
Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
|
|
WO1994007469A1
(en)
*
|
1992-09-25 |
1994-04-14 |
Dynagen, Inc. |
An immunobooster for delayed release of immunogen
|
|
EP1013270A3
(en)
*
|
1992-12-02 |
2001-03-28 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release growth hormone containing microspheres
|
|
UA61046C2
(en)
*
|
1992-12-07 |
2003-11-17 |
Takeda Chemical Industries Ltd |
Sustained-release preparation and method for its manufacture
|
|
TW333456B
(en)
*
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
WO1994021289A1
(en)
*
|
1993-03-22 |
1994-09-29 |
THE UNITED STATES OF AMERICA, as represented by THE SECRERATY OF THE ARMY |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
|
US5456917A
(en)
*
|
1993-04-12 |
1995-10-10 |
Cambridge Scientific, Inc. |
Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
|
|
US6939546B2
(en)
|
1993-05-21 |
2005-09-06 |
The United States Of America As Represented By The Secretary Of The Army |
Model for testing immunogenicity of peptides
|
|
US5603960A
(en)
*
|
1993-05-25 |
1997-02-18 |
O'hagan; Derek T. |
Preparation of microparticles and method of immunization
|
|
US6080429A
(en)
*
|
1993-10-25 |
2000-06-27 |
Genentech, Inc. |
Method for drying microspheres
|
|
US5643605A
(en)
*
|
1993-10-25 |
1997-07-01 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
|
PL314481A1
(en)
|
1993-11-19 |
1996-09-16 |
Janssen Pharmaceutica Nv |
Microencapsulated substituted 3-piperidinyl 1,2-benzoisoxazoles and 1,2-benzoisothiazoles
|
|
WO1995024929A2
(en)
*
|
1994-03-15 |
1995-09-21 |
Brown University Research Foundation |
Polymeric gene delivery system
|
|
EP1125577B1
(en)
*
|
1994-04-08 |
2006-02-15 |
QLT USA, Inc. |
Liquid drug delivery compositions
|
|
US5876735A
(en)
*
|
1994-04-22 |
1999-03-02 |
Corixa Corporation |
Methods for enhancement of protective immune responses
|
|
US6013268A
(en)
|
1994-04-22 |
2000-01-11 |
Corixa Corporation |
Methods for enhancement of protective immune responses
|
|
US6855331B2
(en)
|
1994-05-16 |
2005-02-15 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
|
US6447796B1
(en)
|
1994-05-16 |
2002-09-10 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
|
US5583114A
(en)
|
1994-07-27 |
1996-12-10 |
Minnesota Mining And Manufacturing Company |
Adhesive sealant composition
|
|
USRE38827E1
(en)
|
1994-07-27 |
2005-10-11 |
3M Innovative Properties Company |
Adhesive sealant composition
|
|
KR100201352B1
(ko)
*
|
1995-03-16 |
1999-06-15 |
성재갑 |
단일주사 백신 제형
|
|
US7033608B1
(en)
|
1995-05-22 |
2006-04-25 |
The United States Of America As Represented By The Secretary Of The Army |
“Burst-free” sustained release poly-(lactide/glycolide) microspheres
|
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
|
AUPN366795A0
(en)
*
|
1995-06-20 |
1995-07-13 |
Peptide Technology Limited |
Formulation for preventing reproductive function
|
|
WO1997007788A2
(en)
*
|
1995-08-31 |
1997-03-06 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
|
IL123506A
(en)
|
1995-09-01 |
2004-12-15 |
Corixa Corp |
Polypeptide compounds and preparations for immunotherapy and diagnosis of tuberculosis
|
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
US6592877B1
(en)
*
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
TW448055B
(en)
*
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
|
US5942253A
(en)
*
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
|
ATE192334T1
(de)
|
1995-11-09 |
2000-05-15 |
Microbiological Res Authority |
Mikroverkapselte dna zur impfung und gentherapie
|
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
|
WO1998008533A1
(en)
*
|
1996-08-30 |
1998-03-05 |
Peptech Limited |
Sustained peptide-release formulation
|
|
US5968895A
(en)
*
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
|
US6203813B1
(en)
|
1997-01-13 |
2001-03-20 |
Lance L. Gooberman |
Pharmaceutical delivery device and method of preparation therefor
|
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
EP2284186A1
(en)
|
1997-02-12 |
2011-02-16 |
Corixa Corporation |
Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
|
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
|
ZA982968B
(en)
|
1997-04-09 |
1998-10-27 |
Corixa Corp |
Compositions and methods for the treatment and diagnosis of breast cancer
|
|
AR012448A1
(es)
*
|
1997-04-18 |
2000-10-18 |
Ipsen Pharma Biotech |
Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
|
|
US7087713B2
(en)
*
|
2000-02-25 |
2006-08-08 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
|
WO1999033869A2
(en)
|
1997-12-24 |
1999-07-08 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
|
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
EP2003201A3
(en)
|
1998-03-18 |
2008-12-31 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
|
NZ507378A
(en)
|
1998-04-07 |
2002-12-20 |
Corixa Corp |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
|
EP1079967A4
(en)
|
1998-04-13 |
2003-07-23 |
Luminex Corp |
LIQUID MARKING USING FLUORESCENT MICROPARTICLES
|
|
US7128927B1
(en)
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
|
KR100293504B1
(ko)
|
1998-06-05 |
2001-07-12 |
김윤 |
서방형전립선염치료제조성물
|
|
US6248057B1
(en)
|
1998-07-28 |
2001-06-19 |
Innerdyne, Inc. |
Absorbable brachytherapy and chemotherapy delivery devices and methods
|
|
DK2272859T3
(en)
|
1998-08-07 |
2015-01-19 |
Univ Washington |
Immunological herpes simplex virus antigens and methods for their use
|
|
US6013122A
(en)
*
|
1998-08-18 |
2000-01-11 |
Option Technologies, Inc. |
Tattoo inks
|
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
|
EP1131038A1
(en)
|
1998-11-20 |
2001-09-12 |
The General Hospital Corporation |
Permanent, removable tissue markings
|
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
|
TR200102500T2
(tr)
|
1998-12-08 |
2002-03-21 |
Corixa Corporation |
Chlamydia enfeksiyonunu tedavi etmek iin bileçikler.
|
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6579973B1
(en)
|
1998-12-28 |
2003-06-17 |
Corixa Corporation |
Compositions for the treatment and diagnosis of breast cancer and methods for their use
|
|
EA005140B1
(ru)
|
1999-04-02 |
2004-12-30 |
Корикса Корпорейшн |
Соединения и способы для лечения и диагностики рака легкого
|
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
|
US6306425B1
(en)
|
1999-04-09 |
2001-10-23 |
Southern Research Institute |
Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
|
|
WO2001024820A1
(en)
*
|
1999-10-07 |
2001-04-12 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
|
US6682754B2
(en)
|
1999-11-24 |
2004-01-27 |
Willmar Poultry Company, Inc. |
Ovo delivery of an immunogen containing implant
|
|
US6575888B2
(en)
|
2000-01-25 |
2003-06-10 |
Biosurface Engineering Technologies, Inc. |
Bioabsorbable brachytherapy device
|
|
US6576263B2
(en)
|
2000-02-17 |
2003-06-10 |
3M Innovative Properties Company |
Delivery systems using preformed biodegradable polymer compositions and methods
|
|
KR100848973B1
(ko)
|
2000-02-23 |
2008-07-30 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
종양 특이적 동물 단백질
|
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
|
ES2303525T3
(es)
|
2000-04-21 |
2008-08-16 |
Corixa Corporation |
Compuestos y metodos para el tratamiento y diagnostico de infeccion por chlamydia.
|
|
US20040142475A1
(en)
*
|
2000-06-02 |
2004-07-22 |
Barman Shikha P. |
Delivery systems for bioactive agents
|
|
EP2133100B1
(en)
*
|
2000-06-20 |
2011-10-05 |
Corixa Corporation |
MTB32A Antigen of mycobacterium tuberculosis with inactivated active site and fusion proteins thereof
|
|
EP1319069B1
(en)
|
2000-06-28 |
2008-05-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
KR100392501B1
(ko)
*
|
2000-06-28 |
2003-07-22 |
동국제약 주식회사 |
다중 에멀젼법에 의한 서방출성 미립구의 제조방법
|
|
US20040158317A1
(en)
*
|
2000-07-18 |
2004-08-12 |
Pharmasonics, Inc. |
Coated stent with ultrasound therapy
|
|
US6296842B1
(en)
|
2000-08-10 |
2001-10-02 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
|
US6479065B2
(en)
|
2000-08-10 |
2002-11-12 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
|
US6824822B2
(en)
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
|
ES2326209T3
(es)
|
2000-10-27 |
2009-10-05 |
Baxter Healthcare S.A. |
Produccion de microesferas.
|
|
US20040122090A1
(en)
*
|
2001-12-07 |
2004-06-24 |
Lipton Stuart A. |
Methods for treating neuropsychiatric disorders with nmda receptor antagonists
|
|
CA2432900C
(en)
|
2000-12-21 |
2007-09-11 |
Nektar Therapeutics |
Induced phase transition method for the production of microparticles containing hydrophilic active agents
|
|
US20030050692A1
(en)
*
|
2000-12-22 |
2003-03-13 |
Avantec Vascular Corporation |
Delivery of therapeutic capable agents
|
|
US6471980B2
(en)
|
2000-12-22 |
2002-10-29 |
Avantec Vascular Corporation |
Intravascular delivery of mycophenolic acid
|
|
US20050203612A1
(en)
*
|
2000-12-22 |
2005-09-15 |
Avantec Vascular Corporation |
Devices delivering therapeutic agents and methods regarding the same
|
|
US20020082679A1
(en)
*
|
2000-12-22 |
2002-06-27 |
Avantec Vascular Corporation |
Delivery or therapeutic capable agents
|
|
US7018405B2
(en)
|
2000-12-22 |
2006-03-28 |
Avantec Vascular Corporation |
Intravascular delivery of methylprednisolone
|
|
US20030033007A1
(en)
*
|
2000-12-22 |
2003-02-13 |
Avantec Vascular Corporation |
Methods and devices for delivery of therapeutic capable agents with variable release profile
|
|
US7077859B2
(en)
*
|
2000-12-22 |
2006-07-18 |
Avantec Vascular Corporation |
Apparatus and methods for variably controlled substance delivery from implanted prostheses
|
|
US6939375B2
(en)
|
2000-12-22 |
2005-09-06 |
Avantac Vascular Corporation |
Apparatus and methods for controlled substance delivery from implanted prostheses
|
|
US7083642B2
(en)
|
2000-12-22 |
2006-08-01 |
Avantec Vascular Corporation |
Delivery of therapeutic capable agents
|
|
US20020082678A1
(en)
*
|
2000-12-22 |
2002-06-27 |
Motasim Sirhan |
Intravascular delivery of mizoribine
|
|
IL156955A0
(en)
|
2001-01-17 |
2004-02-08 |
Genecraft Inc |
Binding domain-immunoglobulin fusion proteins
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7829084B2
(en)
*
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
US7618939B2
(en)
*
|
2001-02-15 |
2009-11-17 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods to prevent cancer with cupredoxins
|
|
US7491394B2
(en)
|
2001-02-15 |
2009-02-17 |
The Board Of Trustees Of The University Of Illinois |
Cytotoxic factors for modulating cell death
|
|
US6537195B2
(en)
|
2001-05-07 |
2003-03-25 |
Xoft, Microtube, Inc. |
Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasia
|
|
US7018371B2
(en)
*
|
2001-05-07 |
2006-03-28 |
Xoft, Inc. |
Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia
|
|
WO2002089747A2
(en)
|
2001-05-09 |
2002-11-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
EP1408876A4
(en)
|
2001-06-22 |
2004-09-22 |
Durect Corp |
ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE
|
|
CA2452382A1
(en)
|
2001-07-10 |
2003-01-23 |
Corixa Corporation |
Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
|
|
WO2003009778A2
(en)
*
|
2001-07-26 |
2003-02-06 |
Avantec Vascular Corporation |
Methods and devices for delivery of therapeutic capable agents with variable release profile
|
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
|
PT1418890E
(pt)
*
|
2001-08-16 |
2008-06-09 |
Baxter Int |
Formulações de micropartículas à base de propulsor
|
|
EP1434835A4
(en)
|
2001-09-13 |
2010-02-17 |
Ansell Healthcare Prod Llc |
MICROCOATING COATING FOR GLOVES
|
|
DK2279755T3
(da)
|
2001-10-10 |
2014-05-26 |
Ratiopharm Gmbh |
Remodellering og glycokonjugering af fibroblastvækstfaktor (FGF)
|
|
US20060062807A1
(en)
|
2001-12-11 |
2006-03-23 |
Marie-Anne Nahori |
Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
|
|
EP1581119B1
(en)
|
2001-12-17 |
2013-01-30 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
|
PL216224B1
(pl)
|
2002-02-01 |
2014-03-31 |
Ariad Pharmaceuticals |
Pochodne rapamycyny zawierające fosfor, kompozycja je zawierająca oraz ich zastosowanie
|
|
AU2003213118A1
(en)
|
2002-02-15 |
2003-09-09 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
|
DK2561860T3
(en)
*
|
2002-05-31 |
2018-04-30 |
Titan Pharmaceuticals Inc |
Implantable polymer device for prolonged release of buprenorphine
|
|
US7157102B1
(en)
|
2002-05-31 |
2007-01-02 |
Biotek, Inc. |
Multi-layered microcapsules and method of preparing same
|
|
US7041320B1
(en)
|
2002-05-31 |
2006-05-09 |
Biotek, Inc. |
High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
|
|
EP2865386B1
(en)
|
2002-07-18 |
2017-07-05 |
University of Washington |
Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments
|
|
US7736391B2
(en)
|
2003-02-06 |
2010-06-15 |
Tonaba Healthscience Ii, Llc |
Cosmetic and reconstructive prostheses with a microencapsulated biologically compatible rupture indicator for sustained release and methods of detecting compromise of a prosthesis
|
|
BRPI0408157B8
(pt)
|
2003-03-07 |
2021-05-25 |
Dsm Food Specialties B V |
ácido nucléico recombinante, polipeptídeo recombinante com atividade lipase, célula transformada, métodos empregando os mesmos e composição
|
|
CA2519092C
(en)
|
2003-03-14 |
2014-08-05 |
Neose Technologies, Inc. |
Branched water-soluble polymers and their conjugates
|
|
KR101152183B1
(ko)
*
|
2003-03-31 |
2012-06-15 |
타이탄 파머슈티컬즈 인코퍼레이티드 |
도파민 아고니스트의 지속 방출을 위한 이식가능한 폴리머디바이스
|
|
US20070010702A1
(en)
*
|
2003-04-08 |
2007-01-11 |
Xingwu Wang |
Medical device with low magnetic susceptibility
|
|
US20040254419A1
(en)
*
|
2003-04-08 |
2004-12-16 |
Xingwu Wang |
Therapeutic assembly
|
|
EP2338333B1
(en)
|
2003-04-09 |
2017-09-06 |
ratiopharm GmbH |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
US20070207211A1
(en)
*
|
2003-04-10 |
2007-09-06 |
Pr Pharmaceuticals, Inc. |
Emulsion-based microparticles and methods for the production thereof
|
|
CN101410174B
(zh)
*
|
2003-04-10 |
2011-04-06 |
Pr药品有限公司 |
一种用于生产基于乳化的微观粒子的方法
|
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
|
EA015166B1
(ru)
|
2003-06-16 |
2011-06-30 |
Ю-Си-Би Мэньюфэкчуринг, Инк. |
Иммуногенные пептиды склеростина (sost), индуцирующие образование специфических антител
|
|
CA2532302C
(en)
*
|
2003-07-15 |
2016-12-20 |
Pr Pharmaceuticals, Inc. |
Method for the preparation of controlled release formulations
|
|
AU2004280158B2
(en)
*
|
2003-07-18 |
2011-02-17 |
Baxter International, Inc. |
Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
|
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
|
CA2532874A1
(en)
*
|
2003-07-22 |
2005-02-03 |
Baxter International Inc. |
Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
|
|
AU2004259209A1
(en)
*
|
2003-07-23 |
2005-02-03 |
Pr Pharmaceuticals, Inc. |
Controlled release compositions
|
|
US20070149496A1
(en)
*
|
2003-10-31 |
2007-06-28 |
Jack Tuszynski |
Water-soluble compound
|
|
WO2005051229A2
(en)
*
|
2003-11-24 |
2005-06-09 |
Avantec Vascular Corporation |
Devices delivering therapeutic agents and methods regarding the same
|
|
ES2616337T3
(es)
|
2003-12-12 |
2017-06-12 |
Government Of The United States Of America, As Repr. By The Secr. Of The Dept. Of Health And Human Services And His Successors |
Un epítopo de linfocito T citotóxico humano y su epítopo agonista del número no variable de secuencias de repetición en tándem de MUC-1
|
|
TW200529890A
(en)
*
|
2004-02-10 |
2005-09-16 |
Takeda Pharmaceutical |
Sustained-release preparations
|
|
MXPA06009377A
(es)
|
2004-02-20 |
2007-03-07 |
Lifescape Biosciences Inc |
Composiciones y metodos para regulacion del sueno.
|
|
US20070027523A1
(en)
*
|
2004-03-19 |
2007-02-01 |
Toner John L |
Method of treating vascular disease at a bifurcated vessel using coated balloon
|
|
EP1735042B1
(en)
*
|
2004-03-19 |
2011-11-23 |
Abbott Laboratories |
Multiple drug delivery from a balloon and a prosthesis
|
|
US8431145B2
(en)
*
|
2004-03-19 |
2013-04-30 |
Abbott Laboratories |
Multiple drug delivery from a balloon and a prosthesis
|
|
US20100030183A1
(en)
*
|
2004-03-19 |
2010-02-04 |
Toner John L |
Method of treating vascular disease at a bifurcated vessel using a coated balloon
|
|
US20050249667A1
(en)
*
|
2004-03-24 |
2005-11-10 |
Tuszynski Jack A |
Process for treating a biological organism
|
|
EA200601904A1
(ru)
|
2004-04-15 |
2007-02-27 |
Алкермес, Инк. |
Система отсроченного высвобождения лекарственного средства на основе полимеров
|
|
US7456254B2
(en)
*
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
|
US20050239723A1
(en)
*
|
2004-04-27 |
2005-10-27 |
Amin Avinash N |
Compositions and methods useful for treatment of acne
|
|
EP1758558B1
(en)
*
|
2004-05-12 |
2013-10-16 |
Baxter International Inc. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
|
JP2007537284A
(ja)
|
2004-05-12 |
2007-12-20 |
バクスター インターナショナル インコーポレイテッド |
核酸マイクロスフェア、その生成および送達
|
|
US8728525B2
(en)
*
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
|
US8333995B2
(en)
*
|
2004-05-12 |
2012-12-18 |
Baxter International, Inc. |
Protein microspheres having injectable properties at high concentrations
|
|
CA2837748C
(en)
|
2004-05-25 |
2016-03-08 |
Oregon Health And Science University |
Siv and hiv vaccination using rhcmv-and hcmv-based vaccine vectors
|
|
US7604978B2
(en)
|
2004-07-14 |
2009-10-20 |
Sequoia Sciences, Inc. |
Inhibition of biofilm formation
|
|
DK2199801T3
(da)
|
2004-07-14 |
2013-08-05 |
Univ California |
Biomarkører til tidlig påvisning af ovariecancer
|
|
US20060014285A1
(en)
*
|
2004-07-14 |
2006-01-19 |
Eldridge Gary R |
Methods and compositions for inhibiting biofilms
|
|
US20060264411A1
(en)
*
|
2005-05-20 |
2006-11-23 |
Eldridge Gary R |
Control of biofilm formation
|
|
US9132116B2
(en)
*
|
2004-08-02 |
2015-09-15 |
Willowcroft Pharm Inc. |
Mast cell stabilizers to prevent or treat laminitis
|
|
WO2006078320A2
(en)
*
|
2004-08-04 |
2006-07-27 |
Brookwood Pharmaceuticals, Inc. |
Methods for manufacturing delivery devices and devices thereof
|
|
WO2006031943A1
(en)
|
2004-09-14 |
2006-03-23 |
Eldridge Gary R |
Compounds, compositions and methods for controlling biofilms and bacterial infections
|
|
CA2587084C
(en)
|
2004-10-08 |
2019-07-16 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Modulation of replicative fitness by using less frequently used synonym ous codons
|
|
MX2007006120A
(es)
|
2004-11-23 |
2007-12-07 |
Adamas Pharmaceuticals Inc |
Metodo y composicion para administrar a un sujeto un antagonista del receptor de nmda.
|
|
US8058291B2
(en)
|
2005-04-06 |
2011-11-15 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of CNS-related conditions
|
|
US7619007B2
(en)
*
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
|
US8389578B2
(en)
|
2004-11-24 |
2013-03-05 |
Adamas Pharmaceuticals, Inc |
Composition and method for treating neurological disease
|
|
US20070150051A1
(en)
*
|
2005-01-10 |
2007-06-28 |
Duke Fiduciary, Llc |
Vascular implants and methods of fabricating the same
|
|
US8287583B2
(en)
*
|
2005-01-10 |
2012-10-16 |
Taheri Laduca Llc |
Apparatus and method for deploying an implantable device within the body
|
|
EP2514757A3
(en)
|
2005-01-10 |
2014-03-05 |
ratiopharm GmbH |
Glycopegylated granulocyte colony stimulating factor
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
US9050393B2
(en)
*
|
2005-02-08 |
2015-06-09 |
Bruce N. Saffran |
Medical devices and methods for modulation of physiology using device-based surface chemistry
|
|
EP1701165A1
(en)
|
2005-03-07 |
2006-09-13 |
Johannes Dr. Coy |
Therapeutic and diagnostic uses of TKTL1 and inhibitors and activators thereof
|
|
KR20070121814A
(ko)
|
2005-03-31 |
2007-12-27 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
클라미디아 감염에 대비한 백신
|
|
US20060228384A1
(en)
*
|
2005-04-06 |
2006-10-12 |
Sequoia Sciences, Inc. |
Control of biofilm with a biofilm inhibitor
|
|
EP2386571B1
(en)
|
2005-04-08 |
2016-06-01 |
ratiopharm GmbH |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
|
WO2006116546A1
(en)
*
|
2005-04-27 |
2006-11-02 |
Baxter International Inc. |
Surface-modified microparticles and methods of forming and using the same
|
|
ES2524572T3
(es)
|
2005-04-29 |
2014-12-10 |
Glaxosmithkline Biologicals S.A. |
Procedimiento novedoso de prevención o tratamiento de infección por M. tuberculosis
|
|
US7968694B2
(en)
|
2005-07-01 |
2011-06-28 |
Forsyth Dental Infirmary For Children |
Tuberculosis antigen detection assays and vaccines
|
|
KR100741867B1
(ko)
*
|
2005-07-05 |
2007-07-24 |
전북대학교산학협력단 |
수중유적 및 용매 증발법을 이용한 이중층 미립구의제조방법
|
|
US20070014739A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Eldridge Gary R |
Compositions and methods for controlling biofilms and bacterial infections
|
|
RU2486204C2
(ru)
|
2005-07-22 |
2013-06-27 |
Уай'З Терапьютикс Ко., Лтд. |
Антитела против сd26 и способы их применения
|
|
PT1912675E
(pt)
|
2005-07-25 |
2014-05-09 |
Emergent Product Dev Seattle |
Moléculas de ligaçao especificas para cd37 e especificas para cd20
|
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
|
EP1929073A4
(en)
*
|
2005-09-27 |
2010-03-10 |
Amunix Inc |
PROTEIN MEDICAMENT AND ITS USE
|
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
KR101245919B1
(ko)
*
|
2005-12-22 |
2013-03-20 |
노파르티스 아게 |
옥트레오티드 및 ２종 이상의 폴리락티드-코-글리콜리드중합체를 포함하는 서방형 제제
|
|
US20070190127A1
(en)
|
2005-12-30 |
2007-08-16 |
Mingdong Zhou |
Extended release of neuregulin for improved cardiac function
|
|
US8859209B2
(en)
*
|
2006-01-12 |
2014-10-14 |
Carviar Aps |
Reimmunization and antibody design
|
|
WO2007082105A2
(en)
|
2006-01-16 |
2007-07-19 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chlamydia vaccine
|
|
EP2216403A3
(en)
|
2006-02-02 |
2010-11-24 |
Verenium Corporation |
Esterases and related nucleic acids and methods
|
|
WO2007109583A2
(en)
|
2006-03-17 |
2007-09-27 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
|
|
CA2648718A1
(en)
|
2006-04-07 |
2007-10-18 |
The Research Foundation Of State University Of New York |
Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
|
|
US8859233B2
(en)
*
|
2006-05-02 |
2014-10-14 |
Carviar Aps |
Method for immunizing an avian species
|
|
US10522240B2
(en)
|
2006-05-03 |
2019-12-31 |
Population Bio, Inc. |
Evaluating genetic disorders
|
|
US7702468B2
(en)
|
2006-05-03 |
2010-04-20 |
Population Diagnostics, Inc. |
Evaluating genetic disorders
|
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
|
US20090258028A1
(en)
*
|
2006-06-05 |
2009-10-15 |
Abbott Cardiovascular Systems Inc. |
Methods Of Forming Coatings For Implantable Medical Devices For Controlled Release Of A Peptide And A Hydrophobic Drug
|
|
US8323676B2
(en)
*
|
2008-06-30 |
2012-12-04 |
Abbott Cardiovascular Systems Inc. |
Poly(ester-amide) and poly(amide) coatings for implantable medical devices for controlled release of a protein or peptide and a hydrophobic drug
|
|
US8409577B2
(en)
|
2006-06-12 |
2013-04-02 |
Emergent Product Development Seattle, Llc |
Single chain multivalent binding proteins with effector function
|
|
US8017237B2
(en)
|
2006-06-23 |
2011-09-13 |
Abbott Cardiovascular Systems, Inc. |
Nanoshells on polymers
|
|
EP2056883B1
(en)
|
2006-08-04 |
2021-09-22 |
Baxter International Inc. |
Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
|
|
JP5048773B2
(ja)
|
2006-08-09 |
2012-10-17 |
インターシア セラピューティクス，インコーポレイティド |
浸透圧式デリバリーシステム及びピストンアセンブリー
|
|
EP2486938B1
(en)
|
2006-09-26 |
2018-05-09 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
CA2665480C
(en)
|
2006-10-04 |
2019-11-12 |
Shawn Defrees |
Glycerol linked pegylated sugars and glycopeptides
|
|
CA2663589A1
(en)
*
|
2006-10-06 |
2008-05-22 |
Baxter International Inc. |
Microencapsules containing surface-modified microparticles and methods of forming and using the same
|
|
BRPI0807260A2
(pt)
*
|
2007-02-09 |
2014-06-10 |
Taheri Laduca Llc |
"stent implantável e método de fabricação de um enxerto tubular"
|
|
CN101686939B
(zh)
*
|
2007-04-17 |
2013-03-27 |
巴克斯特国际公司 |
用于肺部投送的核酸微粒
|
|
NZ580447A
(en)
|
2007-04-23 |
2011-06-30 |
Intarcia Therapeutics Inc |
Suspension formulations of insulinotropic peptides and uses thereof
|
|
BRPI0812250B8
(pt)
*
|
2007-06-06 |
2021-05-25 |
Debio Rech Pharmaceutique S A |
composição farmacêutica de liberação lenta de uma triptorelina agonista de lhrh feita de micropartículas e uso da mesma
|
|
US20090148447A1
(en)
*
|
2007-07-06 |
2009-06-11 |
Trubion Pharmaceuticals, Inc. |
Binding Peptides Having a C-terminally Disposed Specific Binding Domain
|
|
CA2695374A1
(en)
*
|
2007-08-15 |
2009-02-19 |
Amunix, Inc. |
Compositions and methods for modifying properties of biologically active polypeptides
|
|
CN101998855A
(zh)
*
|
2007-10-02 |
2011-03-30 |
戴维·布兰斯基 |
用于增强婴儿生长和发育的内源性大麻素
|
|
US8932558B2
(en)
*
|
2007-10-05 |
2015-01-13 |
Plaxgen Inc |
Multi-subunit biological complexes for treatment of plaque-associated diseases
|
|
US7828840B2
(en)
*
|
2007-11-15 |
2010-11-09 |
Med Institute, Inc. |
Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
|
|
US20110081422A1
(en)
*
|
2007-11-19 |
2011-04-07 |
Capsulated Systems Inc. |
Prolonged release of local anesthetics using microparticles and surgery applications
|
|
US8619257B2
(en)
|
2007-12-13 |
2013-12-31 |
Kimberley-Clark Worldwide, Inc. |
Recombinant bacteriophage for detection of nosocomial infection
|
|
JP5502751B2
(ja)
|
2007-12-20 |
2014-05-28 |
エボニック コーポレイション |
低残留溶媒濃度を有する微粒子を調製するためのプロセス
|
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
US10000568B2
(en)
|
2008-04-10 |
2018-06-19 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting EGFR in cancer
|
|
NZ603059A
(en)
*
|
2008-04-11 |
2014-07-25 |
Emergent Product Dev Seattle |
Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
|
ES2554168T3
(es)
|
2008-04-18 |
2015-12-16 |
Baxter International Inc. |
Composición basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nueva aparición
|
|
EP2123748A1
(en)
|
2008-05-20 |
2009-11-25 |
Institut Pasteur |
2'-5'-oligoadenylate synthetase 3 for preventing and treating positive-sense single-stranded rna virus infection
|
|
US8765162B2
(en)
|
2008-06-30 |
2014-07-01 |
Abbott Cardiovascular Systems Inc. |
Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same
|
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
|
US8323615B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
|
US8367427B2
(en)
*
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
|
US8357503B2
(en)
|
2008-08-29 |
2013-01-22 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
|
US8153391B2
(en)
|
2008-08-29 |
2012-04-10 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
|
US8198062B2
(en)
|
2008-08-29 |
2012-06-12 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
|
CA2740087C
(en)
|
2008-10-08 |
2019-07-23 |
Kyphia Pharmaceuticals, Inc. |
Gaba conjugates and methods of use thereof
|
|
JP2012515791A
(ja)
*
|
2009-01-23 |
2012-07-12 |
サーモディクス ファーマシューティカルズ， インコーポレイテッド |
ポリマー混成物由来の放出制御システム
|
|
EP2389413A1
(en)
*
|
2009-01-23 |
2011-11-30 |
Surmodics Pharmaceuticals, Inc. |
Polymer mixtures comprising polymers having different non-repeating units and methods for making and using same
|
|
CN108530543B
(zh)
|
2009-02-03 |
2023-06-23 |
阿穆尼克斯制药公司 |
延伸重组多肽和包含该延伸重组多肽的组合物
|
|
PL2418945T3
(pl)
|
2009-04-15 |
2019-05-31 |
Bmg Pharma S P A |
Kompozycje soli mineralnej - kwasu sulfonowego i sposoby ich stosowania
|
|
MX360448B
(es)
*
|
2009-06-05 |
2018-11-01 |
Infectious Disease Res Inst |
Adyuvantes sinteticos de glucopiranosil-lipido.
|
|
US20110038852A1
(en)
*
|
2009-06-10 |
2011-02-17 |
3-V Biosciences, Inc. |
Antivirals that target transporters, carriers, and ion channels
|
|
US8911766B2
(en)
*
|
2009-06-26 |
2014-12-16 |
Abbott Cardiovascular Systems Inc. |
Drug delivery compositions including nanoshells for triggered drug release
|
|
EP2292260A1
(en)
|
2009-08-13 |
2011-03-09 |
Institut Pasteur |
Use of mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis
|
|
US9062299B2
(en)
|
2009-08-24 |
2015-06-23 |
Amunix Operating Inc. |
Coagulation factor IX compositions and methods of making and using same
|
|
WO2011034950A1
(en)
|
2009-09-16 |
2011-03-24 |
Vaxart, Inc. |
Immunization strategy to prevent h1n1 infection
|
|
CN102917693B
(zh)
*
|
2009-09-17 |
2015-05-20 |
赢创有限公司 |
释放特征不同的植入装置及制造和使用该装置的方法
|
|
EP2480200A2
(en)
*
|
2009-09-22 |
2012-08-01 |
Evonik Degussa Corporation |
Implant devices having varying bioactive agent loading configurations
|
|
RU2753280C2
(ru)
|
2009-09-28 |
2021-08-12 |
Интарсия Терапьютикс, Инк. |
Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
|
|
US20120277180A1
(en)
|
2009-09-30 |
2012-11-01 |
Vitapath Genetics, Inc |
Cofactors and Methods for Use for Individuals
|
|
JP2013509422A
(ja)
|
2009-10-30 |
2013-03-14 |
シーエヌエス セラピューティクス，インク． |
改良されたニュールツリン分子
|
|
US20110104138A1
(en)
|
2009-11-03 |
2011-05-05 |
Institut Pasteur |
Use of the innate immunity gene oasl for preventing or treating infection with negative strand rna viruses
|
|
EP3461889B1
(en)
|
2009-11-19 |
2025-01-29 |
Solis BioDyne OÜ |
Compositions for increasing polypeptide stability and activity, and related methods
|
|
BR112012013487A2
(pt)
|
2009-12-02 |
2017-10-03 |
Adamas Pharmaceuticals Inc |
Composições de amantadina e métodos de uso
|
|
US8951595B2
(en)
*
|
2009-12-11 |
2015-02-10 |
Abbott Cardiovascular Systems Inc. |
Coatings with tunable molecular architecture for drug-coated balloon
|
|
US20110144577A1
(en)
*
|
2009-12-11 |
2011-06-16 |
John Stankus |
Hydrophilic coatings with tunable composition for drug coated balloon
|
|
US8480620B2
(en)
*
|
2009-12-11 |
2013-07-09 |
Abbott Cardiovascular Systems Inc. |
Coatings with tunable solubility profile for drug-coated balloon
|
|
JP2013517233A
(ja)
|
2010-01-13 |
2013-05-16 |
インスティチュート・パスツール・コリア |
抗感染ピリド（１，２−ａ）ピリミジン
|
|
HUE031184T2
(en)
|
2010-01-27 |
2017-06-28 |
Glaxosmithkline Biologicals Sa |
Modified tuberculosis antigens
|
|
WO2011116396A2
(en)
|
2010-03-19 |
2011-09-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists
|
|
US9295663B2
(en)
|
2010-07-14 |
2016-03-29 |
Abbott Cardiovascular Systems Inc. |
Drug coated balloon with in-situ formed drug containing microspheres
|
|
WO2012018387A2
(en)
|
2010-08-02 |
2012-02-09 |
Population Diagnotics, Inc. |
Compositions and methods for discovery of causative mutations in genetic disorders
|
|
AU2011332815A1
(en)
|
2010-11-23 |
2013-05-30 |
Presage Biosciences, Inc. |
Therapeutic methods and compositions for solid delivery
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
WO2012122391A1
(en)
|
2011-03-08 |
2012-09-13 |
3-V Biosciences, Inc. |
Heterocyclic modulators of lipid synthesis
|
|
EP2683736B1
(en)
|
2011-03-09 |
2018-01-17 |
Cell Signaling Technology, Inc. |
Methods and reagents for creating monoclonal antibodies
|
|
EA027236B1
(ru)
|
2011-04-08 |
2017-07-31 |
Иммьюн Дизайн Корп. |
Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
|
|
CN107312075B
(zh)
|
2011-06-17 |
2021-01-12 |
田纳西大学研究基金会 |
A群链球菌多价疫苗
|
|
EP2723365A1
(en)
|
2011-06-21 |
2014-04-30 |
Oncofactor Corporation |
Compositions and methods for the therapy and diagnosis of cancer
|
|
EP2731599B1
(en)
|
2011-07-15 |
2018-10-31 |
NuSirt Sciences, Inc. |
Compositions and methods for modulating metabolic pathways
|
|
US8324264B1
(en)
|
2011-07-22 |
2012-12-04 |
Sequoia Sciences, Inc. |
Inhibitors of bacterial biofilms and related methods
|
|
EP2766483B1
(en)
|
2011-10-10 |
2022-03-23 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
|
CN104023760A
(zh)
|
2011-10-28 |
2014-09-03 |
普莱萨格生命科学公司 |
药物递送方法
|
|
EP2773779B1
(en)
|
2011-11-04 |
2020-10-14 |
Population Bio, Inc. |
Methods and compositions for diagnosing, prognosing, and treating neurological conditions
|
|
JP6368243B2
(ja)
|
2011-11-11 |
2018-08-08 |
フレッド ハッチンソン キャンサー リサーチ センター |
がんのためのサイクリンａ１に標的化されたｔ細胞免疫療法
|
|
TR201908003T4
(tr)
|
2012-02-07 |
2019-06-21 |
Infectious Disease Res Inst |
TLR4 agonistleri içeren gelişmiş adjuvan formülasyonları ve bunların kullanım metotları.
|
|
WO2013120018A1
(en)
|
2012-02-09 |
2013-08-15 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
|
EP3564260B1
(en)
|
2012-02-15 |
2022-10-19 |
Bioverativ Therapeutics Inc. |
Factor viii compositions and methods of making and using same
|
|
BR112014019901A8
(pt)
|
2012-02-15 |
2018-01-02 |
Biogen Idec Inc |
Proteínas de fator viii recombinante
|
|
BR112014021388A2
(pt)
|
2012-02-29 |
2017-07-18 |
Ethicon Endo Surgery Inc |
composições de microbiota e métodos rela-cionados às mesmas
|
|
WO2013134577A2
(en)
|
2012-03-08 |
2013-09-12 |
Detectogen, Inc. |
Leishmaniasis antigen detection assays and vaccines
|
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
|
ES2673556T3
(es)
|
2012-05-16 |
2018-06-22 |
Immune Design Corp. |
Vacunas para el VHS-2
|
|
US9976180B2
(en)
|
2012-09-14 |
2018-05-22 |
Population Bio, Inc. |
Methods for detecting a genetic variation in subjects with parkinsonism
|
|
WO2014052855A1
(en)
|
2012-09-27 |
2014-04-03 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
|
CN108452311A
(zh)
|
2012-11-13 |
2018-08-28 |
纽斯尔特科学公司 |
用于增强能量代谢的组合物和方法
|
|
CN105101958B
(zh)
|
2013-01-15 |
2019-05-17 |
纽斯尔特科学公司 |
治疗肺病状
|
|
CN105228627B
(zh)
|
2013-03-15 |
2018-07-13 |
纽斯尔特科学公司 |
亮氨酸和烟酸降低脂质水平
|
|
KR102039520B1
(ko)
|
2013-04-18 |
2019-11-01 |
이뮨 디자인 코포레이션 |
암 치료에 이용하기 위한 gla 단일요법
|
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
|
WO2014204933A1
(en)
|
2013-06-17 |
2014-12-24 |
Adamas Pharmaceuticals, Inc. |
Amantadine compositions and methods of use
|
|
WO2014210546A1
(en)
|
2013-06-27 |
2014-12-31 |
University Of Washington Through Its Center For Commercialization |
Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders
|
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
|
US10633714B2
(en)
|
2013-07-21 |
2020-04-28 |
Pendulum Therapeutics, Inc. |
Methods and systems for microbiome characterization, monitoring and treatment
|
|
TWI667255B
(zh)
|
2013-08-14 |
2019-08-01 |
美商生物化學醫療公司 |
因子ｖｉｉｉ－ｘｔｅｎ融合物及其用途
|
|
KR20160100329A
(ko)
|
2013-12-20 |
2016-08-23 |
3-브이 바이오사이언시스, 인코포레이티드 |
지질 합성의 헤테로사이클릭 조절물질 및 이들의 조합물
|
|
ES2913858T3
(es)
|
2014-01-07 |
2022-06-06 |
Sagimet Biosciences Inc |
Moduladores heterocíclicos de síntesis de lípidos para uso contra el cáncer e infecciones virales
|
|
BR112016016672A2
(pt)
|
2014-01-21 |
2017-08-08 |
Immune Design Corp |
Uso de uma composição
|
|
EA033248B1
(ru)
|
2014-02-20 |
2019-09-30 |
Вэксарт, Инк. |
Композиция и способ индукции иммунного ответа
|
|
SG11201607075TA
(en)
|
2014-02-27 |
2016-09-29 |
Nusirt Sciences Inc |
Compositions and methods for the reduction or prevention of hepatic steatosis
|
|
US10590433B2
(en)
|
2014-03-14 |
2020-03-17 |
University Of Washington |
Genomic insulator elements and uses thereof
|
|
CN120514834A
(zh)
|
2014-03-28 |
2025-08-22 |
华盛顿大学商业中心 |
乳腺癌和卵巢癌疫苗
|
|
JP6820830B2
(ja)
|
2014-07-18 |
2021-01-27 |
ユニヴァーシティ オブ ワシントン |
がんワクチン組成物およびその使用方法
|
|
WO2016036403A1
(en)
|
2014-09-05 |
2016-03-10 |
Population Diagnostics Inc. |
Methods and compositions for inhibiting and treating neurological conditions
|
|
WO2016054240A1
(en)
|
2014-09-30 |
2016-04-07 |
Sean Dalziel |
Fixed dose combinations for the treatment of viral diseases
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
CA2964467A1
(en)
|
2014-10-14 |
2016-04-21 |
Research Development Foundation |
Methods for generating engineered enzymes
|
|
EP3212001A4
(en)
|
2014-10-31 |
2018-04-25 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
|
CN107249318A
(zh)
|
2014-12-10 |
2017-10-13 |
明尼苏达大学董事会 |
用于治疗疾病的遗传修饰的细胞、组织和器官
|
|
ES2910049T3
(es)
|
2015-03-19 |
2022-05-11 |
Sagimet Biosciences Inc |
Moduladores heterocíclicos de la síntesis de lípidos
|
|
ES2832504T3
(es)
|
2015-06-12 |
2021-06-10 |
Vaxart Inc |
Formulaciones para administración de antígenos de norovirus y rsv en el intestino delgado
|
|
IL257231B
(en)
|
2015-08-03 |
2022-09-01 |
Bioverativ Therapeutics Inc |
Factor ix fusion proteins and methods of making and using same
|
|
US11352426B2
(en)
|
2015-09-21 |
2022-06-07 |
Aptevo Research And Development Llc |
CD3 binding polypeptides
|
|
KR20180118105A
(ko)
|
2015-12-04 |
2018-10-30 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
면역치료를 위한 slc45a2 펩티드
|
|
CN109069480A
(zh)
|
2015-12-30 |
2018-12-21 |
阿达玛斯医药公司 |
用于治疗与癫痫相关的病症的方法和组合物
|
|
EP3452516A4
(en)
|
2016-05-04 |
2019-11-27 |
Abilita Bio, Inc. |
Methods and platform for preparing multispanning membrane proteins
|
|
CN109310743A
(zh)
|
2016-05-16 |
2019-02-05 |
因塔西亚制药公司 |
胰高血糖素受体选择性多肽及其使用方法
|
|
JP7195147B2
(ja)
|
2016-05-16 |
2022-12-23 |
アクセス ツー アドバンスト ヘルス インスティチュート |
Ｐｅｇ化リポソームおよび使用方法
|
|
DK3458475T3
(da)
|
2016-05-16 |
2022-09-12 |
Access To Advanced Health Inst |
Formulering, der indeholder tlr-agonist, og anvendelsesfremgangsmåder
|
|
KR102748354B1
(ko)
|
2016-06-01 |
2024-12-31 |
액세스 투 어드밴스드 헬스 인스티튜트 |
사이징제를 함유하는 나노명반 입자
|
|
US11725232B2
(en)
|
2016-10-31 |
2023-08-15 |
The Hong Kong University Of Science And Technology |
Compositions, methods and kits for detection of genetic variants for alzheimer's disease
|
|
EP3548066A1
(en)
|
2016-12-02 |
2019-10-09 |
Bioverativ Therapeutics Inc. |
Methods of treating hemophilic arthropathy using chimeric clotting factors
|
|
MX2019008006A
(es)
|
2017-01-03 |
2019-08-29 |
Intarcia Therapeutics Inc |
Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
|
|
US10240205B2
(en)
|
2017-02-03 |
2019-03-26 |
Population Bio, Inc. |
Methods for assessing risk of developing a viral disease using a genetic test
|
|
EP4445878A3
(en)
|
2017-02-28 |
2025-01-29 |
University College Cork-National University of Ireland Cork |
An intravascular cell therapy device
|
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
|
US20200115324A1
(en)
|
2017-06-11 |
2020-04-16 |
Molecular Express, Inc. |
Methods and compositions for substance use disorder vaccine formulations and uses thereof
|
|
KR20240096685A
(ko)
|
2017-06-15 |
2024-06-26 |
액세스 투 어드밴스드 헬스 인스티튜트 |
나노구조 지질 담체 및 안정적인 에멀션 그리고 이들의 용도
|
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
|
CA3073838A1
(en)
|
2017-08-30 |
2019-03-07 |
Pendulum Therapeutics, Inc. |
Methods and compositions for treatment of microbiome-associated disorders
|
|
CN119930795A
(zh)
|
2017-10-12 |
2025-05-06 |
得克萨斯大学体系董事会 |
用于免疫疗法的t细胞受体
|
|
CN110123789A
(zh)
*
|
2018-02-02 |
2019-08-16 |
山东墨海生物科技有限公司 |
一种载利培酮的plga微球混合物及其制备方法
|
|
AU2019217207B2
(en)
|
2018-02-12 |
2025-12-18 |
Diabetes-Free, Inc. |
Improved antagonistic anti-human CD40 monoclonal antibodies
|
|
HRP20250709T1
(hr)
|
2018-05-18 |
2025-08-15 |
Bioverativ Therapeutics Inc. |
Postupci liječenja hemofilije a
|
|
BR112020026361A2
(pt)
|
2018-06-29 |
2021-03-30 |
Wuhan Neurophth Biotechnology Limited Company |
Composições e métodos para tratar neuropatia óptica hereditária de leber
|
|
WO2020001657A1
(en)
|
2018-06-29 |
2020-01-02 |
Wuhan Neurophth Biological Technology Limited Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
|
AU2019306649A1
(en)
|
2018-07-19 |
2021-02-04 |
Pendulum Therapeutics, Inc. |
Methods and compositions for microbial engraftment
|
|
DK3625368T3
(da)
|
2018-08-08 |
2022-12-19 |
Pml Screening Llc |
Fremgangsmåder til vurdering af risiko for udvikling af progressiv, multifokal leukoencephalopati forårsaget af john cunningham-virus ved genetisk test
|
|
EP3840785A4
(en)
|
2018-08-20 |
2022-07-13 |
Wuhan Neurophth Biotechnology Limited Company |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF LEBERIAN OPTIC ATROPHY
|
|
EP3851120A4
(en)
|
2018-09-11 |
2022-04-27 |
Shanghai Public Health Clinical Center |
Immunogen for broad-spectrum influenza vaccine and application thereof
|
|
WO2020067887A1
(en)
|
2018-09-24 |
2020-04-02 |
Erasmus University Medical Center Rotterdam |
Specific inhibition of janus kinase 3 (jak3) for modulating anti-tumor immune responses
|
|
WO2020102454A1
(en)
|
2018-11-13 |
2020-05-22 |
Regents Of The University Of Minnesota |
Cd40 targeted peptides and uses thereof
|
|
CN119409834A
(zh)
|
2019-08-12 |
2025-02-11 |
北京恩瑞尼生物科技股份有限公司 |
用于通过cd39表达细胞的adcc靶向促进和增强t细胞介导的免疫反应的方法和组合物
|
|
WO2021074695A1
(en)
|
2019-10-16 |
2021-04-22 |
Avacta Life Sciences Limited |
PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
|
|
CN113025633B
(zh)
|
2019-12-09 |
2024-08-27 |
武汉纽福斯生物科技有限公司 |
编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
|
|
AU2021275239A1
(en)
|
2020-05-21 |
2022-12-15 |
Board Of Regents, The University Of Texas System |
T cell receptors with VGLL1 specificity and uses thereof
|
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
|
AU2021337493A1
(en)
|
2020-09-04 |
2023-05-18 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
|
CA3173951A1
(en)
|
2020-09-04 |
2022-03-10 |
Emily VOIGT |
Genetically-adjuvanted rna vaccines
|
|
EP4208195A1
(en)
|
2020-09-04 |
2023-07-12 |
Access to Advanced Health Institute |
Live-attenuated rna hybrid vaccine technology
|
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
|
EP4368203A4
(en)
|
2021-07-05 |
2025-09-24 |
Wuhan Neurophth Biotechnology Ltd Company |
CONSTRUCTION AND USE OF ANTI-VEGF ANTIBODIES IN AN IN VIVO EXPRESSION SYSTEM
|
|
JP2024529033A
(ja)
|
2021-08-06 |
2024-08-01 |
ウーハン ニューロフス バイオテクノロジー リミテッド カンパニー |
Ｎｄ４変異により引き起こされるレーベル遺伝性視神経症を治療するための組成物及び方法
|
|
TW202334196A
(zh)
|
2021-10-07 |
2023-09-01 |
英商阿法克塔生命科學有限公司 |
Pd-l1結合多肽
|
|
US20240409638A1
(en)
|
2021-10-07 |
2024-12-12 |
Avacta Life Sciences Limited |
Serum half-life extended pd-l1 binding polypeptides
|
|
WO2023153876A1
(ko)
|
2022-02-10 |
2023-08-17 |
주식회사 아피셀테라퓨틱스 |
Cd40l에 특이적으로 결합하는 스테핀 a 단백질 변이체 및 이의 용도
|
|
CN118354793A
(zh)
|
2022-04-29 |
2024-07-16 |
普瑞诺生物科技公司 |
用于治疗嗜酸性粒细胞驱动的疾病和病症的方法和组合物
|
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
|
IL319329A
(en)
|
2022-09-09 |
2025-05-01 |
Access To Advanced Health Inst |
Immunogenic vaccine composition incorporating saponin
|